Credit Suisse Ag Ice Cure Medical Ltd. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.01 - $3.31 $112,551 - $185,346
-55,996 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.73 - $8.7 $152,869 - $487,165
55,996 New
55,996 $52.5 Million

Others Institutions Holding ICCM

# of Institutions
16
Shares Held
195K
Call Options Held
0
Put Options Held
0
View Full List

About IceCure Medical Ltd.

ICCM Quotes by TradingView
  • Ticker ICCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,835,600
  • Market Cap $29.1M
  • Description
  • IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
More about ICCM
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email